Levothyroxine Sodium
- Product NDC
- 0527-4959
- 11-digit product format
- 005274959
- Labeler code
- 0527
- Product ID
- 0527-4959_e91be09f-93f4-2893-e053-2995a90a6e40
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levothyroxine sodium
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- NDA021924
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-11-02
- Marketing end
- 0000-00-00
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 137 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0527-4959 | LEVOTHYROXINE SODIUM CAPSULE [LANNETT COMPANY, INC.] | 9 | Legacy NDC | 20240606_686ba2cf-7651-44de-9b4d-eeaaf2a0e364.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0527-4959-32 | 00527495932 | 3 BLISTER PACK in 1 CARTON (0527-4959-32) > 10 CAPSULE in 1 BLISTER PACK | 3 blister pack | 2020-11-02 | 0000-00-00 | No | No | Current |